Skip to main content
. 2024 Jun 14;12(6):661. doi: 10.3390/vaccines12060661
2,5-DHAP 2,5-dihydroxyacetophenone
Ab/Abs antibody/antibodies
AEC addition of 3-amino-9-ethylcarbazole
APCs antigen-presenting cells
AI avidity index
CMV cucumber mosaic virus
CP capsid or coat protein
CuMV cucumber mosaic virus-derived virus-like particles
CuMVTT immunologically optimized cucumber mosaic virus-derived VLPs with incorporated universal Th-cell epitope from tetanus toxin
DENV dengue virus
DLS dynamic light scattering
DV1 EDIII third domain of dengue virus 1 envelope protein
eGFP enhanced green fluorescent protein
ELISA enzyme-linked immunosorbent assay
FRNT focus reduction virus neutralization test
IB inclusion bodies
MS mass spectrometry
NAGE native agarose gel electrophoresis
nCMV N-terminal fragment of the cucumber mosaic virus capsid protein containing the functional R domain
ON overnight
PADRE universal synthetic non-natural Pan DR Epitope
PAMPs pathogen-associated molecular patterns
PASPs Pathogen-associated structural patterns
PMSF phenylmethylsulfonyl fluoride
RT room temperature
SATA N-succinimidyl S-acetylthioacetate
s.c. subcutaneous
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis
SMPH succinimidyl 6-((β-maleimidopropionamido) hexanoate
TEM transmission electron microscopy
Th T-cell help
Th cell T-helper cell
TLR toll-like receptor
TMB tetramethylbenzidine
TT tetanus toxin
VLPs virus-like particles
WT wild type